Lysophosphatidic acid causes endothelial dysfunction in porcine coronary arteries and human coronary artery endothelial cells
- 31 May 2012
- journal article
- Published by Elsevier BV in Atherosclerosis
- Vol. 222 (1), 74-83
- https://doi.org/10.1016/j.atherosclerosis.2012.02.010
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Autotaxin--an LPA producing enzyme with diverse functionsThe Journal of Biochemistry, 2010
- Lysophosphatidic acid regulates inflammation-related genes in human endothelial cells through LPA1 and LPA3Biochemical and Biophysical Research Communications, 2007
- Role of lipoprotein-associated lysophospholipids in migratory activity of coronary artery smooth muscle cellsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- Thrombogenic and atherogenic activities of lysophosphatidic acidJournal of Cellular Biochemistry, 2004
- Endothelial FunctionCirculation, 2004
- Vascular Remodeling Induced by Naturally Occurring Unsaturated Lysophosphatidic Acid In VivoCirculation, 2003
- Role for 18:1 Lysophosphatidic Acid as an Autocrine Mediator in Prostate Cancer CellsOnline Journal of Public Health Informatics, 2002
- Sphingosine-1-Phosphate and Lysophosphatidic Acid Stimulate Endothelial Cell MigrationArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesionsProceedings of the National Academy of Sciences of the United States of America, 1999
- Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cellsCell, 1995